Skip to main content

Loiasis

  • Chapter
  • First Online:
Arthropod Borne Diseases

Abstract

Loa loa is a long-lived parasite (up to 20 years of age) which is transmitted through the bites of deer flies (mainly Chrysops dimidiata and C. silacea). L. loa is endemic to Africa, from southeastern Benin in the west to southern Sudan in the east, and down south to Angola and possibly Zambia. Loiasis was first identified during the slave trade period. At that time, the disease was depicted by the spectacular passage of the adult worm under the bulbar conjunctiva of the eye (“eye worm”) and the transient episodes of subcutaneous migratory edema referred to as “Calabar swelling.” Since then, loiasis has also been associated with more severe symptoms such as cardiopathy (involving hypereosinophilia), nephropathy, and hormonal disturbance. Despite its endemic presence in Central Africa, with possibly tens of millions individuals concerned by the disease, loiasis has drawn little attention until the implementation of mass drug administration for lymphatic filariasis and onchocerciasis in the region. Indeed, post-therapeutic serious adverse events (SAEs) have occurred in individuals harboring high density of L. loa microfilariae. Solutions to prevent those SAEs are currently under evaluation in the field, but specific operational research on loiasis should nonetheless be encouraged.

Due to the intimate relationship among lymphatic filariasis, onchocercosis, mansonelliasis, and loiasis on diagnosis, distribution, and treatment, all four chapters need to be checked when solving problems related to any of them (CBM).

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 249.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Akue JP, Hommel M, Devaney E (1997) High levels of parasite-specific IgG1 correlate with the amicrofilaremic state in Loa loa infection. J Infect Dis 175:158–163

    Article  CAS  PubMed  Google Scholar 

  • Bakajika DK, Nigo MM, Lotsima JP et al (2014) Filarial antigenemia and Loa loa night blood microfilaremia in an area without bancroftian filariasis in the Democratic Republic of Congo. Am J Trop Med Hyg. doi:10.4269/ajtmh.14-0358

  • Bennuru S, Pion SD, Kamgno J et al (2014) Repurposed automated handheld counter as a point-of-care tool to identify individuals ‘at risk’ of serious post-ivermectin encephalopathy. PLoS Negl Trop Dis 8, e3180. doi:10.1371/journal.pntd.0003180

    Article  PubMed  PubMed Central  Google Scholar 

  • Bhedasgaonkar S, Baile RB, Nadkarni S et al (2011) Loa loa macrofilariasis in the eyelid: case report of the first periocular subcutaneous manifestation in India. J Parasit Dis 35:230–231. doi:10.1007/s12639-011-0043-6

    Article  PubMed  PubMed Central  Google Scholar 

  • Blum J, Wiestner A, Fuhr P, Hatz C (2001) Encephalopathy following Loa loa treatment with albendazole. Acta Trop 78:63–65

    Article  CAS  PubMed  Google Scholar 

  • Boussinesq M (2006) Loiasis. Ann Trop Med Parasitol 100:715–731. doi:10.1179/136485906X112194

    Article  CAS  PubMed  Google Scholar 

  • Boussinesq M (2012) Loiasis: new epidemiologic insights and proposed treatment strategy. J Travel Med 19:140–143

    Article  PubMed  Google Scholar 

  • Boussinesq M, Gardon J (1997) Prevalences of Loa loa microfilaraemia throughout the area endemic for the infection. Ann Trop Med Parasitol 91:573–589

    Article  CAS  PubMed  Google Scholar 

  • Boussinesq M, Gardon J, Gardon-Wendel N et al (2003) Clinical picture, epidemiology and outcome of Loa-associated serious adverse events related to mass ivermectin treatment of onchocerciasis in Cameroon. Filaria J 2(Suppl 1):S4. doi:10.1186/1475-2883-2-S1-S4

  • Burchard GD, Kern P (1987) Failure of high dose mebendazole as a microfilaricide in patients with loiasis. Trans R Soc Trop Med Hyg 81:420

    Article  CAS  PubMed  Google Scholar 

  • Carme B, Boulesteix J, Boutes H et al (1991a) Five cases of encephalitis during treatment of loiasis with diethylcarbamazine. Am J Trop Med Hyg 44:684–690

    CAS  PubMed  Google Scholar 

  • Carme B, Ebkili B, Mbitsi A et al (1991b) Essai thérapeutique de l’ivermectine au cours de la loase à moyenne et forte microfilarémie. Ann Soc Belg Med Trop 71:47–50

    CAS  PubMed  Google Scholar 

  • Chesnais CB (2014) Recherches épidémiologiques appliquées à la lutte contre les filarioses en Afrique centrale. PhD thesis, Université de Montpellier, France

    Google Scholar 

  • D’Ambrosio MV, Bakalar M, Bennuru S et al (2015) Rapid, point-of-care quantification of Loa loa microfilariae in human whole blood with a mobile phone microscope. Sci Transl Med 7:286. doi:10.1126/scitranslmed.aaa3480

    Google Scholar 

  • Drame PM, Fink DL, Kamgno J et al (2014) Loop-mediated isothermal amplification for rapid and semiquantitative detection of Loa loa infection. J Clin Microbiol 52:2071–2077. doi:10.1128/JCM.00525-14

    Article  PubMed  PubMed Central  Google Scholar 

  • Duke BOL (1958) Studies on the biting habits of Chrysops. V. The biting-cycles and infection rates of C. silacea, C. dimidiata, C. langi and C. centurionis at canopy level in the rain-forest at Bombe, British Cameroons. Ann Trop Med Parasitol 52:24–35

    Article  CAS  PubMed  Google Scholar 

  • Duke BOL (1963) Studies on the chemoprophylaxis of loiasis II. Observations on diethylcarbamazine citrate (Banocide) as a prophylactic in man. Trop Med Parasitol 57:82–96

    Article  Google Scholar 

  • Duke BOL (2004) Failed attempts at experimental transplantation and transmission of nocturnally-periodic simian Loa from monkey to man. Filaria J 3:5. doi:10.1186/1475-2883-3-5

    Article  PubMed  PubMed Central  Google Scholar 

  • Duke BO, Lewis DJ (1964) Studies on factors influencing the transmission of onchocerciasis. III. Observations on the effect of the peritrophic membrane in limiting the development of Onchocerca volvulus microfilariae in Simulium damnosum. Ann Trop Med Parasitol 58:83–88

    Article  CAS  PubMed  Google Scholar 

  • Eveland LK, Yermakov V, Kenney M (1975) Loa loa infection without microfilaraemia. Trans R Soc Trop Med Hyg 69:354–355

    Article  CAS  PubMed  Google Scholar 

  • Fain A (1978) Les problèmes actuels de la loase. Bull World Health Organ 56:155–167

    CAS  PubMed  PubMed Central  Google Scholar 

  • Fain A, Maertens K (1973) Notes sur la ponte des microfilaires chez Loa loa et sur le degré de maturité des vers en migration. Bull Soc Pathol Exot 66:737–742

    Google Scholar 

  • Fink DL, Kamgno J, Nutman TB (2011) Rapid molecular assays for specific detection and quantitation of Loa loa microfilaremia. PLoS Negl Trop Dis 5, e1299. doi:10.1371/journal.pntd.0001299.t003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Fobi G, Gardon J, Santiago M et al (2000) Ocular findings after ivermectin treatment of patients with high Loa loa microfilaremia. Ophthalmic Epidemiol 7:27–39

    Article  CAS  PubMed  Google Scholar 

  • Garcia A, Abel L, Cot M et al (1999) Genetic epidemiology of host predisposition microfilaraemia in human loiasis. Trop Med Int Health 4:565–574

    Article  CAS  PubMed  Google Scholar 

  • Gardon J, Gardon-Wendel N, Demanga-Ngangue et al (1997) Serious reactions after mass treatment of onchocerciasis with ivermectin in an area endemic for Loa loa infection. Lancet 350:18–22. doi:10.1016/S0140-6736(96)11094-1

  • Goussard B, Ivanoff B, Frost E et al (1984) Age of appearance of IgG, IgM, and IgE antibodies specific for Loa loa in Gabonese children. Microbiol Immunol 28:787–792

    Article  CAS  PubMed  Google Scholar 

  • Kamgno J, Gardon J, Boussinesq M (2000) Essai de prévention des encé́phalopathies à Loa loa post-ivermectine par l’administration d’une faible dose initiale. Med Trop 60:275–277

    CAS  Google Scholar 

  • Kamgno J, Djomo PN, Pion SD et al (2010) A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia. Am J Trop Med Hyg 82:379–385. doi:10.4269/ajtmh.2010.09-0573

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Klion AD, Nutman TB (2011) Loiasis and Mansonella infections. In: Richard L (ed) Tropical infectious diseases: principles, pathogens, and practice, 2nd ed. Saunders and Elsevier Edinburgh, pp 1163–1175. Source: http://www.sciencedirect.com/science/article/pii/B9780702039355001427

  • Klion AD, Massougbodji A, Horton J et al (1993) Albendazole in human loiasis: results of a double-blind, placebo-controlled trial. J Infect Dis 168:202–206

    Article  CAS  PubMed  Google Scholar 

  • Klion AD, Ottesen EA, Nutman TB (1994) Effectiveness of diethylcarbamazine in treating loiasis acquired by expatriate visitors to endemic regions: long-term follow-up. J Infect Dis 169:604–610

    Article  CAS  PubMed  Google Scholar 

  • The Mectizan® Expert Committee, The Technical Consultative Committee (2004) Recommendations for the treatment of Onchocerciasis with Mectizan® in areas co-endemic for Onchocerciasis and Loiasis. http://www.who.int/apoc/publications/englishmectccloarecs-june04.pdf

  • Metzger WG, Mordmüller B (2014) Loa loa—does it deserve to be neglected? Lancet Infect Dis 14:353–357. doi:10.1016/S1473-3099(13)70263-9

    Article  PubMed  Google Scholar 

  • Negesse YY, Lanoie LOL, Neafie RCR, Connor DHD (1985) Loiasis: “Calabar” swellings and involvement of deep organs. Am J Trop Med Hyg 34:537–546

    CAS  PubMed  Google Scholar 

  • Nutman TB, Miller KD, Mulligan M et al (1988) Diethylcarbamazine prophylaxis for human loiasis. Results of a double-blind study. N Engl J Med 319:752–756. doi:10.1056/NEJM198809223191204

    Article  CAS  PubMed  Google Scholar 

  • Orihel TC, Eberhard ML (1985) Loa loa: development and course of patency in experimentally-infected primates. Trop Med Parasitol 36:215–224

    CAS  PubMed  Google Scholar 

  • Orihel TC, Moore PJ (1975) Loa loa: experimental infection in two species of African primates. Am J Trop Med Hyg 24:606–609

    CAS  PubMed  Google Scholar 

  • PATH (2014) New test will combat major cause of preventable blindness in Africa. http://www.path.org/news/press-room/703/. Accessed 26 Feb 2015

  • Pion SD, Montavon C, Chesnais CB et al (2014) Correlation between high Loa loa microfilaremia and levels of circulating filarial antigens used to detect Wuchereria bancrofti infection. ASTMH 63rd annual meeting, New Orleans, 2–6 Nov 2014

    Google Scholar 

  • Pion SD, Chesnais CB, Bopda J et al (2015) The impact of mass drug administration with albendazole alone on lymphatic filariasis and soil-transmitted helminth infections: a community-based study in the Republic of Congo. Am J Trop Med Hyg 92:959–966

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Richard-Lenoble D, Kombila M, Burnier I, Maganga ML (1985) Filarioses au Gabon: traitement par le mebendazole des filarioses à M. perstans et Loa loa. Bull Soc Pathol Exot 78:485–491

    CAS  Google Scholar 

  • Richardson ET, Luo R, Fink DL et al (2012) Transient facial swellings in a patient with a remote African travel history. J Travel Med 19:183–185. doi:10.1111/j.1708-8305.2012.00612.x

    Article  PubMed  PubMed Central  Google Scholar 

  • Twum-Danso NAY, Meredith SEO (2003) Variation in incidence of serious adverse events after onchocerciasis treatment with ivermectin in areas of Cameroon co-endemic for loiasis. Trop Med Int Health 8:820–831. doi:10.1046/j.1365-3156.2003.01091.x

    Article  PubMed  Google Scholar 

  • Van Bogaert L, Dubois A, Janssens PG et al (1955) Encephalitis in Loa loa filariasis. J Neurol Neurosurg Psychiatry 18:103–119

    Article  PubMed Central  Google Scholar 

  • Van Hoegaerden M, Ivanoff B, Flocard F et al (1987) The use of mebendazole in the treatment of filariases due to Loa loa and Mansonella perstans. Ann Trop Med Parasitol 81:275–282

    Article  PubMed  Google Scholar 

  • WHO (2010) Map of the estimated prevalence of eye worm history in Africa. WHO. http://www.who.int/apoc/raploa/en/

  • WHO (2012) Provisional strategies for interrupting lymphatic filariasis transmission in loiasis-endemic countries. Report on the meeting on lymphatic filariasis, malaria and integrated vector management. http://apps.who.int/iris/bitstream/10665/75139/3/WHO_HTM_NTD_PCT_2012.6_eng.pdf

  • Zouré HGM, Wanji S, Noma M et al (2011) The geographic distribution of Loa loa in Africa: results of large-scale implementation of the Rapid Assessment Procedure for Loiasis (RAPLOA). PLoS Negl Trop Dis 5, e1210. doi:10.1371/journal.pntd.0001210.t002

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sébastien Pion .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Pion, S., Chesnais, C. (2017). Loiasis. In: Marcondes, C. (eds) Arthropod Borne Diseases. Springer, Cham. https://doi.org/10.1007/978-3-319-13884-8_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-13884-8_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-13883-1

  • Online ISBN: 978-3-319-13884-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics